Chronic Lymphocytic Leukemia (CLL) Clinical Trials


Natural Killer Cells and Bortezomib to Treat Cancer

Conditions:   Lung or Prostatic Neoplasms;   Colorectal or Kidney Neoplasms;   Pancreatic Neoplasms;   Leukemia, Myelogenous, Chronic Lymphocytic Leukemia, BCR-ABL Positive;   Melanoma;   CLL
Intervention:   Drug: NK cells +CliniMACs CD3 and CD56 systems
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified May 16, 2017

Learn More

Alemtuzumab (Campath ) to Treat T-Large Granular Lymphocyte Leukemia

Condition:   Lymphoproliferative Disorders
Intervention:   Drug: Alemtuzumab (Campath)
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified May 16, 2017

Learn More

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

Conditions:   Waldenstrom Macroglobulinemia;   Chronic Lymphocytic Leukemia;   Hodgkin Disease;   NonHodgkin Lymphoma;   Mixed Lymphoproliferative Disease
Intervention:  
Sponsor:   National Cancer Institute (NCI)
Recruiting - verified June 9, 2017

Learn More

Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

Conditions:   Hematologic Disease;   Lymphoma;   Multiple Myeloma;   Myelodysplastic Syndrome;   Myeloproliferative Disorder
Intervention:   Procedure: Stem cell transplantation
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified August 10, 2016

Learn More

31-34 of 34
Results per page

Join the community!


You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.